Discover
PBYI
Puma Biotechnology, Inc.
8.83
2 x 8.81
2 x 8.84
bid
ask
+
0.14
1.61%
12:37 PM
timesize
| Ytd | 48.41% | |
| 1y | 82.06% |
8.48
day range
8.88
4.30
52 week range
9.40
| Open | 8.80 | Prev Close | 8.69 | Low | 8.48 | High | 8.88 | Mkt Cap | 449.19M |
| Vol | 88.99K | Avg Vol | 308.51K | EPS | 0.61 | P/E | 14.47 | Forward P/E | 11.71 |
| Beta | 1.22 | Short Ratio | 5.09 | Inst. Own | 67.74% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 7.80 | 200-d Avg | 6.68 | 1yr Est | 4.33 |
| Income Statement | |||
| Total Revenue | 56.50M | ||
| Revenues (USD) | 56.50M | ||
| Cost of Revenue | 12.48M | ||
| Gross Profit | 44.03M | ||
| Operating Expenses | 36.44M | ||
| Research and Development Expense | 18.90M | ||
| Selling, General and Administrative Expense | 17.55M | ||
| Operating Income | 7.59M | ||
| Interest Expense | 180.00K | ||
| Income Tax Expense | 56.00K | ||
| Net Income | 8.19M | ||
| Net Income Common Stock | 8.19M | ||
| Net Income Common Stock (USD) | 8.19M | ||
| Consolidated Income | 8.19M | ||
| Earnings per Basic Share | 0.16 | ||
| Earnings per Basic Share (USD) | 0.16 | ||
| Earnings per Diluted Share | 0.16 | ||
| Earning Before Interest & Taxes (EBIT) | 8.43M | ||
| Earning Before Interest & Taxes (USD) | 8.43M | ||
| Weighted Average Shares | 50.94M | ||
| Weighted Average Shares Diluted | 52.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 36.54M | ||
| Cash and Equivalents (USD) | 36.54M | ||
| Investments | 57.37M | ||
| Investments Current | 57.37M | ||
| Trade and Non-Trade Receivables | 34.06M | ||
| Current Assets | 145.07M | ||
| Property, Plant & Equipment Net | 4.52M | ||
| Total Assets | 192.74M | ||
| Debt Current | 450.00K | ||
| Total Debt | 4.82M | ||
| Current Liabilities | 49.83M | ||
| Debt Non-Current | 4.37M | ||
| Total Liabilities | 54.19M | ||
| Accumulated Retained Earnings (Deficit) | -1.28B | ||
| Accumulated Other Comprehensive Income | -45.00K | ||
| Shareholders Equity | 138.54M | ||
| Shareholders Equity (USD) | 138.54M | ||
| Assets Non-Current | 47.66M | ||
| Total Debt (USD) | 4.82M | ||
| Goodwill and Intangible Assets | 36.52M | ||
| Inventory | 13.32M | ||
| Liabilities Non-Current | 4.37M | ||
| Trade and Non-Trade Payables | 3.11M | ||
| Tax Assets | 3.83M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.52M | ||
| Net Cash Flow from Financing | -11.34M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.75M | ||
| Issuance (Repayment) of Debt Securities | -11.12M | ||
| Net Cash Flow from Investing | 7.97M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 7.97M | ||
| Net Cash Flow from Operations | 1.62M | ||
| Share Based Compensation | 1.95M | ||